Markets
AZN

Sector Update: Healthcare Shares Flat Pre-Market; Geron Gets Partial Clinical Hold Lifted

Top Healthcare stocks:

JNJ: flat

PFE: +0.34%

ABT: flat

MRK: flat

AMGN: flat

Healthcare shares were fairly flat in pre-market trade on Thursday.

In healthcare stocks news, Geron ( GERN ) has announced the U.S. Food and Drug Administration has

removed the partial clinical hold on the investigator-sponsored clinical trial of imetelstat in myelofibrosis (Myelofibrosis IST). The partial clinical hold was placed in March 2014 due to a safety signal of hepatotoxicity identified in clinical trials.

And, Amgen ( AMGN ) and AstraZeneca ( AZN ) late Wednesday reported positive results from a Phase 2 study evaluating brodalumab in 168 patients with psoriatic arthritis.

Brodalumab is the companies' investigational treatment that binds to the interleukin-17 (IL-17) receptor and inhibits inflammatory signaling by blocking the binding of several IL-17 ligands to the receptor. The IL-17 pathway plays a central role in inducing and promoting inflammatory disease processes.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AZN GERN AMGN

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More